• OPEN AN ACCOUNT
Indian Indices
Sensex
84,273.92 208.17
( 0.25%)
Global Indices
Nasdaq
50,149.26 12.58
(0.03%)
Dow Jones
6,984.17 30.87
(0.44%)
Hang Seng
57,678.97 1,315.03
(2.33%)
Nikkei 225
10,354.92 -31.31
(-0.30%)
Forex
USD-INR
90.44 0.11
(0.13%)
EUR-INR
106.84 0.33
(0.31%)
GBP-INR
123.03 0.35
(0.29%)
JPY-INR
0.58 0.00
(-0.07%)

EQUITY - MARKET SCREENER

Titan Biotech Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524717
INE150C01011
189.4317315
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
40.96
843.56
EPS(TTM)
Face Value()
Div & Yield %
24.92
10
0.2
 

avantel ltd
XPRO India consolidated net profit declines 50.00% in the September 2025 quarter
Nov 06,2025
Net profit of XPRO India declined 50.00% to Rs 4.97 crore in the quarter ended September 2025 as against Rs 9.94 crore during the previous quarter ended September 2024. Sales declined 10.50% to Rs 119.91 crore in the quarter ended September 2025 as against Rs 133.98 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales119.91133.98 -11
OPM %6.1110.00 -
PBDT9.6816.57 -42
PBT6.7013.72 -51
NP4.979.94 -50